The Promises and Limitations of N -Acetylcysteine as a Potentiator of First-Line and Second-Line Tuberculosis Drugs
- 19 April 2021
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 65 (5)
- https://doi.org/10.1128/aac.01703-20
Abstract
N-acetylcysteine (NAC) is most commonly used for the treatment of acetaminophen overdose and acetaminophen-induced liver injury. In patients infected with Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), NAC is given to treat hepatotoxicity induced by TB drugs. We had previously shown that cysteine, a derivative of NAC, potentiated the activity of isoniazid, a first-line TB drug, by preventing the emergence of INH resistance and persistence in M. tuberculosis in vitro. Herein, we demonstrate that in vitro, NAC has the same boosting activity with various combinations of first- and second-line TB drugs against drug-susceptible and multidrug-resistant M. tuberculosis strains. Similar to cysteine, NAC increased M. tuberculosis respiration. However, in M. tuberculosis-infected mice, the addition of NAC did not augment the activity of first- or second-line TB drugs. A comparison of the activity of NAC combined with TB drugs in murine and human macrophage cell lines revealed that studies in mice might not be recapitulated during host infection in vivo.Funding Information
- HHS | National Institutes of Health (AI132940, AI026170, AI111276, P30CA013330)
This publication has 22 references indexed in Scilit:
- Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivoThe Journal of Experimental Medicine, 2016
- Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefitsPharmacology & Therapeutics, 2014
- The chemistry and biological activities of N-acetylcysteineBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- The Roles of Glutathione, Glutathione Peroxidase, Glutathione Reductase and the Carbonyl Protein in Pulmonary and Extra Pulmonary TuberculosisJournal of Clinical and Diagnostic Research, 2012
- Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicityEuropean Journal of Gastroenterology & Hepatology, 2010
- Genome Analysis of Multi- and Extensively-Drug-Resistant Tuberculosis from KwaZulu-Natal, South AfricaPLOS ONE, 2009
- Suppression of Mycobacterium tuberculosis induced reactive oxygen species (ROS) and TNF‐α mRNA expression in human monocytes by allicinFEBS Letters, 2006
- N-Acetylcystei ne: Pharmacological Considerations and Experimental and Clinical ApplicationsAdvances in Pharmacology, 1996
- Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning.BMJ, 1979
- Laboratory and clinical evaluation of the mucolytic properties of acetylcysteine.Published by Elsevier BV ,1967